Table 2 Baseline prevalence of comorbidity among lung cancer patients and mean survival days by comorbidity and stage of lung cancer at diagnosis
From: Decreased survival among lung cancer patients with co-morbid tuberculosis and diabetes
Comorbidity | Stage | P-value | |||||||
|---|---|---|---|---|---|---|---|---|---|
I | II | III | IV | ||||||
N = 214 | N = 104 | N = 399 | N = 378 | ||||||
% | Mean | % | Mean | % | Mean | % | Mean | ||
Other cancer | |||||||||
No | 91.6 | 1235 | 96.2 | 1072 | 94.7 | 718 | 94.4 | 467 | - |
Yes | 8.4 | 1157 | 3.8 | 334 | 5.3 | 829 | 5.6 | 853 | 0.093 |
Tuberculosis | |||||||||
No | 92.5 | 1247 | 89.4 | 1075 | 90.2 | 743 | 89.4 | 500 | - |
Yes | 7.5 | 1002 | 10.6 | 774 | 9.8 | 553 | 10.6 | 395 | 0.004 |
COPD | |||||||||
No | 92.1 | 1213 | 94.2 | 1038 | 95.5 | 726 | 96.3 | 491 | - |
Yes | 7.9 | 1408 | 5.8 | 1123 | 4.5 | 685 | 3.7 | 435 | <0.001 |
Diabetes | |||||||||
No | 86.9 | 1280 | 90.4 | 1065 | 88.7 | 752 | 88.1 | 492 | - |
Yes | 13.1 | 889 | 9.6 | 836 | 11.3 | 503 | 11.9 | 466 | 0.008 |
Hypertension | |||||||||
No | 70.1 | 1209 | 77.9 | 1111 | 75.4 | 757 | 73.0 | 498 | - |
Yes | 29.9 | 1275 | 22.1 | 806 | 24.6 | 622 | 27.0 | 465 | <0.001 |